Gilead Joining the Global Access to Oncology Medicines Coalition
By:
3BL Media
June 08, 2022 at 05:55 AM EDT
SOURCE: Gilead Sciences
DESCRIPTION:
We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb
About Gilead
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
View original content here
KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM
![]()
More News
View More
Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care ↗
November 29, 2025
Via MarketBeat
SoFi Technologies: From Fintech Speculation to Profit Engine ↗
November 29, 2025
Via MarketBeat
Gold to $5,000? What Bank of America and UBS Have to Say ↗
November 29, 2025
Via MarketBeat
MarketBeat Week in Review – 11/24 - 11/28 ↗
November 29, 2025
Power On: Applied Digital’s First AI Data Center Goes Live ↗
November 28, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>